Vericel (VCEL) Share-based Compensation (QoQ) (2010 - 2026)
Powered by 
Analysis
Vericel (VCEL) Share-based Compensation (QoQ) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn |
| 10 | Taysha Gene Therapies | 1.97 Bn | 1.97 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -19.58% |
| Mar 31, 2026 | 34.09% |
| Dec 31, 2025 | -3.17% |
| Sep 30, 2025 | -14.21% |
| Jun 30, 2025 | -11.86% |
| Mar 31, 2025 | 45.32% |
| Dec 31, 2024 | -14.17% |
| Sep 30, 2024 | -3.11% |
| Jun 30, 2024 | -3.19% |
| Mar 31, 2024 | -21.60% |
| Dec 31, 2023 | 58.30% |
| Sep 30, 2023 | -9.55% |
| Jun 30, 2023 | 0.34% |
| Mar 31, 2023 | 12.80% |
| Dec 31, 2022 | -14.98% |
| Sep 30, 2022 | -15.77% |
| Jun 30, 2022 | 13.40% |
| Mar 31, 2022 | 21.55% |
| Dec 31, 2021 | -8.78% |
| Sep 30, 2021 | -20.89% |